#USA #mental health #Plano #Bipolar Depression #Salience TMS

Innovative Treatment for Bipolar Depression

Recent research published by Salience TMS Neuro Solutions unveils a groundbreaking approach in the treatment of bipolar depression through a novel single-day transcranial magnetic stimulation (TMS) regimen. The study, described in the paper titled Real-world effectiveness of a single-day course of transcranial magnetic stimulation using an Optimized, Neuroplasticity-Enhanced regimen in Bipolar Depression (ONE-BD), surveyed 30 adults with bipolar I disorder who were experiencing depressive episodes.

TMS therapy operates by delivering magnetic stimulation to targeted areas of the brain associated with mood regulation. Traditionally, TMS treatment consists of daily sessions over several weeks. The ONE-BD case series tested the feasibility and effectiveness of compressing this treatment into one day, where all 20 sessions occurred within a single day, each lasting approximately 3 minutes and spaced 20 minutes apart.

Patients also received a single dose of D-cycloserine, a medication believed to bolster the effects of TMS based on previous studies. Remarkably, all participants completed the full treatment regimen without serious adverse events or switches to mania or hypomania.

Regarding treatment outcomes, the follow-up period lasted for 12 weeks post-treatment. Impressive results were observed with 73.3% of patients meeting criteria for a response and 43.3% achieving remission according to the 17-item Hamilton Depression Rating Scale (HDRS-17) by the six-week mark. Participants reported similar improvements in self-rated mood symptoms, indicating a robust positive trend following the innovative therapy.

Dr. Nancy Donachie, Chief Medical Officer of Salience, emphasized the commitment to improving mental healthcare through research and clinical advancements. She stated, "Our goal is not only to provide exceptional care today, but also to participate in research that asks important questions about how treatment can continue to improve for patients in the future."

The potential of this accelerated interventional psychiatry offers hope to those who have struggled with conventional treatment options that can often yield insufficient results. Research indicates that bipolar depression poses significant challenges to treatment, as many individuals find limited success with traditional medications and therapy. Therefore, developments like the ONE-BD case series could prove transformative in how mental health conditions are treated moving forward.

While the results from the ONE-BD series are considered preliminary, the researchers advocate for further randomized controlled studies to substantiate these promising findings. Salience remains committed to deepening the understanding of TMS therapy and expanding access to effective, evidence-based treatment methodologies.

In conclusion, Salience TMS Neuro Solutions is paving the way for future treatment strategies by exploring innovative approaches such as the single-day TMS treatment. This could offer a beacon of hope for those navigating the complexities of bipolar depression, fostering a future where patients can receive faster, more effective care.

For more detailed insights, you can access the full study and additional resources on TMS therapy through Salience's website.

About Salience TMS Neuro Solutions

Established in 2011, Salience TMS Neuro Solutions is at the forefront of advancing mental healthcare through TMS therapy. With over a million treatments administered, the organization embodies a relentless pursuit of clinical expertise, continual research, and innovative practice in mental health treatment.